🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,067 results for “Hospital” Clear

  1. 20mg Febuxostat

    The First People's Hospital of Lianyungang

    Hyperuricemia

    approved small molecule active

    1 trial

  2. 23-valent pneumococcal polysaccharide vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab completed

    1 trial

  3. 3 % Minoxidil lotion

    Hospital Authority, Hong Kong

    Beard Enhancement

    approved small molecule completed

    1 trial

  4. 30% Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atelectasis

    approved small molecule completed

    1 trial

  5. 30%Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atelectasis, Postoperative

    approved small molecule completed

    1 trial

  6. 37.5mg Pregabalin + 75mg Pregabalin

    The First People's Hospital of Lianyungang

    Pain, Postoperative

    approved small molecule completed

    1 trial

  7. 6-month clopidogrel therapy

    Hospital Authority, Hong Kong

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  8. 60 µg dose hepatitis B vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccine

    approved mab completed

    1 trial

  9. 60 µg dose hepatitis B vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccination

    approved mab completed

    1 trial

  10. 80% Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oxygenation Index

    approved small molecule active

    1 trial

  11. ACEI / ARB+finerenone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Henoch Schönlein Purpura Nephritis

    approved small molecule active

    1 trial

  12. ALA

    The First People's Hospital of Lianyungang

    Actinic Keratoses

    approved small molecule active

    1 trial

  13. AN69ST hemofilter

    The First People's Hospital of Lianyungang

    Critical Ill Patients

    approved other completed

    1 trial

  14. ATRA+Arsenic

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Promyelocytic Leukemia

    approved small molecule active

    1 trial

  15. Acarbose 100 MG

    RenJi Hospital

    PCOS

    approved small molecule active

    1 trial

  16. Adefovir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B, Chronic

    approved small molecule completed

    1 trial

  17. Aerosolized 13 cis retinoic acid plus Vitamin D

    The First People's Hospital of Lianyungang

    Post COVID-19 Anosmia (Loss of Smell)

    approved small molecule active

    1 trial

  18. Alendronate

    Hospital Authority, Hong Kong

    Non-Traumatic Osteonecrosis

    approved small molecule active

    1 trial

  19. Alendronate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Osteogenesis Imperfecta

    approved small molecule completed

    1 trial

  20. Allopurinol Tablet 300 mg

    Hospital Authority, Hong Kong

    Kidney Calculi

    approved small molecule completed

    1 trial

  21. Alprostadil

    The First People's Hospital of Lianyungang

    Stroke

    approved small molecule active

    1 trial

  22. Amlodipine besylate

    The First People's Hospital of Lianyungang

    Hypertension

    approved small molecule active

    1 trial

  23. Anerning particle

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Community-acquired Pneumonia

    approved small molecule active

    1 trial

  24. Anshen Buxin Liuwei Pill

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cardiac Neurosis

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources